Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2018

がん治療のためのチェックポイント阻害薬の世界市場

◆タイトル:Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2018
◆商品コード:QYR802A1093
◆調査・発行会社:QYResearch
◆発行日:2018年1月9日
◆ページ数:106
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥327,700見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD5,800 ⇒換算¥655,400見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、世界のがん治療のためのチェックポイント阻害薬市場について調査・分析し、がん治療のためのチェックポイント阻害薬の世界市場概観、がん治療のためのチェックポイント阻害薬の種類別市場分析、用途別市場分析、がん治療のためのチェックポイント阻害薬の世界市場規模予測、関連企業分析、主要地域別分析(北米市場、ヨーロッパ市場、中国市場、日本市場、アジア市場など)、関連企業情報、価格情報、販売動向、市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・がん治療のためのチェックポイント阻害薬の世界市場概観
・がん治療のためのチェックポイント阻害薬の種類別市場規模
・がん治療のためのチェックポイント阻害薬の用途別市場規模
・がん治療のためのチェックポイント阻害薬の世界市場規模
・がん治療のためのチェックポイント阻害薬の世界市場規模予測
・がん治療のためのチェックポイント阻害薬の主要地域別市場規模
・がん治療のためのチェックポイント阻害薬の北米市場規模・予測
・がん治療のためのチェックポイント阻害薬のヨーロッパ市場規模・予測
・がん治療のためのチェックポイント阻害薬の中国市場規模・予測
・がん治療のためのチェックポイント阻害薬の日本市場規模・予測
・がん治療のためのチェックポイント阻害薬のアジア市場規模・予測
・がん治療のためのチェックポイント阻害薬の製造メーカー分析
・がん治療のためのチェックポイント阻害薬のメーカー別生産量
・がん治療のためのチェックポイント阻害薬のメーカー別市場シェア
・がん治療のためのチェックポイント阻害薬の価格動向・価格分析
・がん治療のためのチェックポイント阻害薬の販売(売上高)動向
・がん治療のためのチェックポイント阻害薬の貿易(輸出・輸入)動向
・がん治療のためのチェックポイント阻害薬の産業チェーン分析
・がん治療のためのチェックポイント阻害薬のマーケティング戦略分析
・がん治療のためのチェックポイント阻害薬の販売業者(代理店)リスト
・がん治療のためのチェックポイント阻害薬の市場環境分析
...

In this report, the global Checkpoint Inhibitors for Treating Cancer market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Checkpoint Inhibitors for Treating Cancer in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Checkpoint Inhibitors for Treating Cancer market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Bristol-Myers Squibb(BMS)
Merck
Roche

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
PD-1 inhibitors
PD-L1 inhibitors
CTLA-4 inhibitors
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Melanoma treatment
Bladder cancer treatment
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2018
1 Checkpoint Inhibitors for Treating Cancer Market Overview
1.1 Product Overview and Scope of Checkpoint Inhibitors for Treating Cancer
1.2 Checkpoint Inhibitors for Treating Cancer Segment by Type (Product Category)
1.2.1 Global Checkpoint Inhibitors for Treating Cancer Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Checkpoint Inhibitors for Treating Cancer Production Market Share by Type (Product Category) in 2017
1.2.3 PD-1 inhibitors
1.2.4 PD-L1 inhibitors
1.2.5 CTLA-4 inhibitors
1.3 Global Checkpoint Inhibitors for Treating Cancer Segment by Application
1.3.1 Checkpoint Inhibitors for Treating Cancer Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Melanoma treatment
1.3.3 Bladder cancer treatment
1.3.4 Other
1.4 Global Checkpoint Inhibitors for Treating Cancer Market by Region (2013-2025)
1.4.1 Global Checkpoint Inhibitors for Treating Cancer Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Checkpoint Inhibitors for Treating Cancer (2013-2025)
1.5.1 Global Checkpoint Inhibitors for Treating Cancer Revenue Status and Outlook (2013-2025)
1.5.2 Global Checkpoint Inhibitors for Treating Cancer Capacity, Production Status and Outlook (2013-2025)

2 Global Checkpoint Inhibitors for Treating Cancer Market Competition by Manufacturers
2.1 Global Checkpoint Inhibitors for Treating Cancer Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Checkpoint Inhibitors for Treating Cancer Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Checkpoint Inhibitors for Treating Cancer Production and Share by Manufacturers (2013-2018)
2.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Share by Manufacturers (2013-2018)
2.3 Global Checkpoint Inhibitors for Treating Cancer Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Checkpoint Inhibitors for Treating Cancer Manufacturing Base Distribution, Sales Area and Product Type
2.5 Checkpoint Inhibitors for Treating Cancer Market Competitive Situation and Trends
2.5.1 Checkpoint Inhibitors for Treating Cancer Market Concentration Rate
2.5.2 Checkpoint Inhibitors for Treating Cancer Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Checkpoint Inhibitors for Treating Cancer Capacity and Market Share by Region (2013-2018)
3.2 Global Checkpoint Inhibitors for Treating Cancer Production and Market Share by Region (2013-2018)
3.3 Global Checkpoint Inhibitors for Treating Cancer Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Checkpoint Inhibitors for Treating Cancer Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Checkpoint Inhibitors for Treating Cancer Consumption by Region (2013-2018)
4.2 North America Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export, Import (2013-2018)
4.3 Europe Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export, Import (2013-2018)
4.4 China Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export, Import (2013-2018)
4.5 Japan Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export, Import (2013-2018)
4.7 India Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export, Import (2013-2018)

5 Global Checkpoint Inhibitors for Treating Cancer Production, Revenue (Value), Price Trend by Type
5.1 Global Checkpoint Inhibitors for Treating Cancer Production and Market Share by Type (2013-2018)
5.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Market Share by Type (2013-2018)
5.3 Global Checkpoint Inhibitors for Treating Cancer Price by Type (2013-2018)
5.4 Global Checkpoint Inhibitors for Treating Cancer Production Growth by Type (2013-2018)

6 Global Checkpoint Inhibitors for Treating Cancer Market Analysis by Application
6.1 Global Checkpoint Inhibitors for Treating Cancer Consumption and Market Share by Application (2013-2018)
6.2 Global Checkpoint Inhibitors for Treating Cancer Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Checkpoint Inhibitors for Treating Cancer Manufacturers Profiles/Analysis
7.1 Bristol-Myers Squibb(BMS)
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Checkpoint Inhibitors for Treating Cancer Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Merck
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Checkpoint Inhibitors for Treating Cancer Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Merck Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Roche
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Checkpoint Inhibitors for Treating Cancer Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Roche Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview

8 Checkpoint Inhibitors for Treating Cancer Manufacturing Cost Analysis
8.1 Checkpoint Inhibitors for Treating Cancer Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Checkpoint Inhibitors for Treating Cancer

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Checkpoint Inhibitors for Treating Cancer Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Checkpoint Inhibitors for Treating Cancer Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Checkpoint Inhibitors for Treating Cancer Market Forecast (2018-2025)
12.1 Global Checkpoint Inhibitors for Treating Cancer Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Checkpoint Inhibitors for Treating Cancer Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Checkpoint Inhibitors for Treating Cancer Price and Trend Forecast (2018-2025)
12.2 Global Checkpoint Inhibitors for Treating Cancer Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Checkpoint Inhibitors for Treating Cancer Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Checkpoint Inhibitors for Treating Cancer Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Checkpoint Inhibitors for Treating Cancer Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Checkpoint Inhibitors for Treating Cancer Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Checkpoint Inhibitors for Treating Cancer Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Checkpoint Inhibitors for Treating Cancer Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Checkpoint Inhibitors for Treating Cancer Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Checkpoint Inhibitors for Treating Cancer Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer

List of Tables and Figures

Figure Picture of Checkpoint Inhibitors for Treating Cancer
Figure Global Checkpoint Inhibitors for Treating Cancer Production (K Doses) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Production Market Share by Types (Product Category) in 2017
Figure Product Picture of PD-1 inhibitors
Table Major Manufacturers of PD-1 inhibitors
Figure Product Picture of PD-L1 inhibitors
Table Major Manufacturers of PD-L1 inhibitors
Figure Product Picture of CTLA-4 inhibitors
Table Major Manufacturers of CTLA-4 inhibitors
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption (K Doses) by Applications (2013-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share by Applications in 2017
Figure Melanoma treatment Examples
Table Key Downstream Customer in Melanoma treatment
Figure Bladder cancer treatment Examples
Table Key Downstream Customer in Bladder cancer treatment
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Checkpoint Inhibitors for Treating Cancer Market Size (Million USD), Comparison (K Doses) and CAGR (%) by Regions (2013-2025)
Figure North America Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity, Production (K Doses) Status and Outlook (2013-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Major Players Product Capacity (K Doses) (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Capacity (K Doses) of Key Manufacturers (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity (K Doses) of Key Manufacturers in 2017
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity (K Doses) of Key Manufacturers in 2018
Figure Global Checkpoint Inhibitors for Treating Cancer Major Players Product Production (K Doses) (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Production (K Doses) of Key Manufacturers (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Production Share by Manufacturers (2013-2018)
Figure 2017 Checkpoint Inhibitors for Treating Cancer Production Share by Manufacturers
Figure 2017 Checkpoint Inhibitors for Treating Cancer Production Share by Manufacturers
Figure Global Checkpoint Inhibitors for Treating Cancer Major Players Product Revenue (Million USD) (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Manufacturers
Table 2018 Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Manufacturers
Table Global Market Checkpoint Inhibitors for Treating Cancer Average Price (USD/Dose) of Key Manufacturers (2013-2018)
Figure Global Market Checkpoint Inhibitors for Treating Cancer Average Price (USD/Dose) of Key Manufacturers in 2017
Table Manufacturers Checkpoint Inhibitors for Treating Cancer Manufacturing Base Distribution and Sales Area
Table Manufacturers Checkpoint Inhibitors for Treating Cancer Product Category
Figure Checkpoint Inhibitors for Treating Cancer Market Share of Top 3 Manufacturers
Figure Checkpoint Inhibitors for Treating Cancer Market Share of Top 5 Manufacturers
Table Global Checkpoint Inhibitors for Treating Cancer Capacity (K Doses) by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity Market Share by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity Market Share by Region (2013-2018)
Figure 2017 Global Checkpoint Inhibitors for Treating Cancer Capacity Market Share by Region
Table Global Checkpoint Inhibitors for Treating Cancer Production by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Production (K Doses) by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Production Market Share by Region (2013-2018)
Figure 2017 Global Checkpoint Inhibitors for Treating Cancer Production Market Share by Region
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) by Region (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Region (2013-2018)
Table 2017 Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Region
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity, Production (K Doses) and Growth Rate (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table North America Checkpoint Inhibitors for Treating Cancer Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Europe Checkpoint Inhibitors for Treating Cancer Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table China Checkpoint Inhibitors for Treating Cancer Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Japan Checkpoint Inhibitors for Treating Cancer Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Southeast Asia Checkpoint Inhibitors for Treating Cancer Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table India Checkpoint Inhibitors for Treating Cancer Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Consumption (K Doses) Market by Region (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share by Region (2013-2018)
Figure 2017 Global Checkpoint Inhibitors for Treating Cancer Consumption (K Doses) Market Share by Region
Table North America Checkpoint Inhibitors for Treating Cancer Production, Consumption, Import & Export (K Doses) (2013-2018)
Table Europe Checkpoint Inhibitors for Treating Cancer Production, Consumption, Import & Export (K Doses) (2013-2018)
Table China Checkpoint Inhibitors for Treating Cancer Production, Consumption, Import & Export (K Doses) (2013-2018)
Table Japan Checkpoint Inhibitors for Treating Cancer Production, Consumption, Import & Export (K Doses) (2013-2018)
Table Southeast Asia Checkpoint Inhibitors for Treating Cancer Production, Consumption, Import & Export (K Doses) (2013-2018)
Table India Checkpoint Inhibitors for Treating Cancer Production, Consumption, Import & Export (K Doses) (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Production (K Doses) by Type (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Production Share by Type (2013-2018)
Figure Production Market Share of Checkpoint Inhibitors for Treating Cancer by Type (2013-2018)
Figure 2017 Production Market Share of Checkpoint Inhibitors for Treating Cancer by Type
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) by Type (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Checkpoint Inhibitors for Treating Cancer by Type (2013-2018)
Figure 2017 Revenue Market Share of Checkpoint Inhibitors for Treating Cancer by Type
Table Global Checkpoint Inhibitors for Treating Cancer Price (USD/Dose) by Type (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Production Growth by Type (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Consumption (K Doses) by Application (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share by Application (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share by Applications (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share by Application in 2017
Table Global Checkpoint Inhibitors for Treating Cancer Consumption Growth Rate by Application (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption Growth Rate by Application (2013-2018)
Table Bristol-Myers Squibb(BMS) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Production Growth Rate (2013-2018)
Figure Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Production Market Share (2013-2018)
Figure Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Revenue Market Share (2013-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Checkpoint Inhibitors for Treating Cancer Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merck Checkpoint Inhibitors for Treating Cancer Production Growth Rate (2013-2018)
Figure Merck Checkpoint Inhibitors for Treating Cancer Production Market Share (2013-2018)
Figure Merck Checkpoint Inhibitors for Treating Cancer Revenue Market Share (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Checkpoint Inhibitors for Treating Cancer Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Roche Checkpoint Inhibitors for Treating Cancer Production Growth Rate (2013-2018)
Figure Roche Checkpoint Inhibitors for Treating Cancer Production Market Share (2013-2018)
Figure Roche Checkpoint Inhibitors for Treating Cancer Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Checkpoint Inhibitors for Treating Cancer
Figure Manufacturing Process Analysis of Checkpoint Inhibitors for Treating Cancer
Figure Checkpoint Inhibitors for Treating Cancer Industrial Chain Analysis
Table Raw Materials Sources of Checkpoint Inhibitors for Treating Cancer Major Manufacturers in 2017
Table Major Buyers of Checkpoint Inhibitors for Treating Cancer
Table Distributors/Traders List
Figure Global Checkpoint Inhibitors for Treating Cancer Capacity, Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Price (Million USD) and Trend Forecast (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Production (K Doses) Forecast by Region (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Production Market Share Forecast by Region (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Consumption (K Doses) Forecast by Region (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption Market Share Forecast by Region (2018-2025)
Figure North America Checkpoint Inhibitors for Treating Cancer Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure North America Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Figure Europe Checkpoint Inhibitors for Treating Cancer Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure Europe Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Figure China Checkpoint Inhibitors for Treating Cancer Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure China Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Figure Japan Checkpoint Inhibitors for Treating Cancer Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure Japan Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Figure India Checkpoint Inhibitors for Treating Cancer Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure India Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Checkpoint Inhibitors for Treating Cancer Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Production (K Doses) Forecast by Type (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Production (K Doses) Forecast by Type (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share Forecast by Type (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Price Forecast by Type (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Consumption (K Doses) Forecast by Application (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Consumption (K Doses) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[がん治療のためのチェックポイント阻害薬の世界市場] (Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2018 / QYR802A1093)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆